Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jeff Jones's Stock Ratings
Oppenheimer Analyst
Jeff Jones is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/01/2025
Overall Average Return
-23.5%
Smart Score
Overall Average Return Percentile
10th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/26/2025 | ZURA | Buy Now | Zura Bio | $1.47 | 1192.52% | Jeff Jones32% | $20 → $19 | Maintains | Outperform | Get Alert |
| 03/26/2025 | CRVS | Buy Now | Corvus Pharma | $3.70 | 305.41% | Jeff Jones32% | $14 → $15 | Maintains | Outperform | Get Alert |
| 01/30/2025 | ALMS | Buy Now | Alumis | $3.83 | 735.51% | Jeff Jones32% | → $32 | Initiates | → Outperform | Get Alert |
| 01/24/2025 | EVH | Buy Now | Evolent Health | $9.95 | 80.9% | Jeff Jones32% | $28 → $18 | Maintains | Outperform | Get Alert |
| 12/11/2024 | CLRB | Buy Now | Cellectar Biosciences | $0.27 | — | Jeff Jones32% | — | Downgrade | Outperform → Perform | Get Alert |
| 11/22/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones32% | $22 → $16 | Maintains | Outperform | Get Alert |
| 11/19/2024 | CLRB | Buy Now | Cellectar Biosciences | $0.27 | 4385.98% | Jeff Jones32% | $14 → $12 | Maintains | Outperform | Get Alert |
| 11/18/2024 | EVH | Buy Now | Evolent Health | $9.95 | 181.41% | Jeff Jones32% | $34 → $28 | Maintains | Outperform | Get Alert |
| 11/18/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.11 | 459.61% | Jeff Jones32% | → $23 | Initiates | → Outperform | Get Alert |
| 11/15/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.38 | 697.33% | Jeff Jones32% | $13 → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2024 | CRVS | Buy Now | Corvus Pharma | $3.70 | 278.38% | Jeff Jones32% | $8 → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 11/08/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 547.9% | Jeff Jones32% | $10 → $9 | Reiterates | Outperform → Outperform | Get Alert |
| 11/08/2024 | EVH | Buy Now | Evolent Health | $9.95 | 241.71% | Jeff Jones32% | $45 → $34 | Maintains | Outperform | Get Alert |
| 10/11/2024 | CLRB | Buy Now | Cellectar Biosciences | $0.27 | 5133.64% | Jeff Jones32% | $14 → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 10/11/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones32% | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 09/27/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 62.08% | Jeff Jones32% | $52 → $56 | Maintains | Outperform | Get Alert |
| 09/10/2024 | AVBP | Buy Now | ArriVent BioPharma | $21.08 | 85.01% | Jeff Jones32% | $35 → $39 | Reiterates | Outperform → Outperform | Get Alert |
| 08/15/2024 | AVBP | Buy Now | ArriVent BioPharma | $21.08 | 66.03% | Jeff Jones32% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 08/13/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones32% | $19 → $17 | Maintains | Outperform | Get Alert |
| 08/09/2024 | IMCR | Buy Now | Immunocore Hldgs | $29.61 | 200.57% | Jeff Jones32% | $87 → $89 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.65 | 2622.49% | Jeff Jones32% | $48 → $45 | Maintains | Outperform | Get Alert |
| 08/07/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.87 | 1018.17% | Jeff Jones32% | $80 → $88 | Maintains | Outperform | Get Alert |
| 07/10/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 50.51% | Jeff Jones32% | $52 → $52 | Maintains | Outperform | Get Alert |
| 07/10/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.87 | 916.52% | Jeff Jones32% | $80 → $80 | Reiterates | Outperform → Outperform | Get Alert |
| 06/18/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones32% | $2 → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 06/07/2024 | MCRB | Buy Now | Seres Therapeutics | $9.50 | — | Jeff Jones32% | — | Downgrade | Outperform → Perform | Get Alert |
| 06/06/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 619.89% | Jeff Jones32% | $12 → $10 | Maintains | Outperform | Get Alert |
| 06/03/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.87 | 916.52% | Jeff Jones32% | $60 → $80 | Maintains | Outperform | Get Alert |
| 05/10/2024 | ZURA | Buy Now | Zura Bio | $1.47 | 1328.57% | Jeff Jones32% | $16 → $21 | Maintains | Outperform | Get Alert |
| 05/09/2024 | MCRB | Buy Now | Seres Therapeutics | $9.50 | -57.89% | Jeff Jones32% | $100 → $80 | Maintains | Outperform | Get Alert |
| 05/08/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.87 | 662.39% | Jeff Jones32% | $58 → $60 | Maintains | Outperform | Get Alert |
| 05/07/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.65 | 2803.99% | Jeff Jones32% | $47 → $48 | Reiterates | Outperform → Outperform | Get Alert |
| 05/07/2024 | CRVS | Buy Now | Corvus Pharma | $3.70 | 116.22% | Jeff Jones32% | $7 → $8 | Maintains | Outperform | Get Alert |
| 05/06/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.38 | 334.91% | Jeff Jones32% | → $6 | Upgrade | Perform → Outperform | Get Alert |
| 05/03/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 50.51% | Jeff Jones32% | $53 → $52 | Maintains | Outperform | Get Alert |
| 04/22/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.55 | 53.4% | Jeff Jones32% | → $53 | Initiates | → Outperform | Get Alert |
| 04/01/2024 | ZURA | Buy Now | Zura Bio | $1.47 | 988.44% | Jeff Jones32% | $17 → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 04/01/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones32% | $12 → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 04/01/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | — | Jeff Jones32% | — | Reiterates | Perform → Perform | Get Alert |
| 03/28/2024 | CLRB | Buy Now | Cellectar Biosciences | $0.27 | 4385.98% | Jeff Jones32% | $11 → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2024 | CRVS | Buy Now | Corvus Pharma | $3.70 | 89.19% | Jeff Jones32% | $8 → $7 | Maintains | Outperform | Get Alert |
| 03/19/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones32% | $12 → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 03/13/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.87 | 636.98% | Jeff Jones32% | $51 → $58 | Reiterates | Outperform → Outperform | Get Alert |
| 03/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 763.87% | Jeff Jones32% | → $12 | Upgrade | Perform → Outperform | Get Alert |
| 03/08/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.38 | — | Jeff Jones32% | — | Maintains | Perform | Get Alert |
| 03/06/2024 | MCRB | Buy Now | Seres Therapeutics | $9.50 | -47.37% | Jeff Jones32% | $180 → $100 | Maintains | Outperform | Get Alert |
| 03/01/2024 | EVH | Buy Now | Evolent Health | $9.95 | 352.26% | Jeff Jones32% | → $45 | Initiates | → Outperform | Get Alert |
| 02/29/2024 | PDCO | Buy Now | Patterson Cos | — | — | Jeff Jones32% | $32 → $30 | Maintains | Neutral | Get Alert |
| 02/21/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | — | Jeff Jones32% | — | Reiterates | → Perform | Get Alert |
| 02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | — | Jeff Jones32% | — | Downgrade | Outperform → Perform | Get Alert |
| 01/29/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.87 | 548.03% | Jeff Jones32% | $20 → $51 | Maintains | Outperform | Get Alert |
| 01/16/2024 | MCRB | Buy Now | Seres Therapeutics | $9.50 | -5.26% | Jeff Jones32% | $200 → $180 | Maintains | Outperform | Get Alert |
| 01/05/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jeff Jones32% | $13 → $15 | Maintains | Outperform | Get Alert |
| 12/27/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jeff Jones32% | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 11/30/2023 | PDCO | Buy Now | Patterson Cos | — | — | Jeff Jones32% | $35 → $32 | Maintains | Neutral | Get Alert |
| 09/29/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jeff Jones32% | → $13 | Initiates | → Outperform | Get Alert |
| 08/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.65 | 3045.99% | Jeff Jones32% | $51 → $52 | Maintains | Outperform | Get Alert |
| 08/09/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.87 | 179.54% | Jeff Jones32% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 07/05/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 4363.32% | Jeff Jones32% | $62 → $62 | Reiterates | Outperform → Outperform | Get Alert |
| 06/22/2023 | PDCO | Buy Now | Patterson Cos | — | — | Jeff Jones32% | $31 → $35 | Maintains | Neutral | Get Alert |
| 06/07/2023 | CMMB | Buy Now | Chemomab Therapeutics | $1.38 | — | Jeff Jones32% | — | Downgrade | Outperform → Perform | Get Alert |
| 06/01/2023 | NOVN | Buy Now | Novan | — | — | Jeff Jones32% | — | Downgrade | Outperform → Perform | Get Alert |
| 05/25/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.24 | 3165.31% | Jeff Jones32% | → $120 | Maintains | Outperform | Get Alert |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | $4.56 | — | Jeff Jones32% | — | Downgrade | Outperform → Perform | Get Alert |
| 05/19/2023 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones32% | $10 → $12 | Maintains | Outperform | Get Alert |
| 05/16/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | Jeff Jones32% | → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | NOVN | Buy Now | Novan | — | — | Jeff Jones32% | $9 → $8 | Maintains | Outperform | Get Alert |
| 05/11/2023 | PMVP | Buy Now | PMV Pharma | $1.00 | 1400% | Jeff Jones32% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.65 | 2985.49% | Jeff Jones32% | $44 → $51 | Maintains | Outperform | Get Alert |
| 05/10/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.87 | 179.54% | Jeff Jones32% | → $22 | Upgrade | Perform → Outperform | Get Alert |
| 04/18/2023 | CMMB | Buy Now | Chemomab Therapeutics | $1.38 | 407.39% | Jeff Jones32% | $12 → $7 | Maintains | Outperform | Get Alert |
| 03/30/2023 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | 2185.71% | Jeff Jones32% | $20 → $24 | Maintains | Outperform | Get Alert |
| 03/24/2023 | MBRX | Buy Now | Moleculin Biotech | $1.02 | 389.62% | Jeff Jones32% | → $75 | Reiterates | → Outperform | Get Alert |
| 03/24/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 4363.32% | Jeff Jones32% | $65 → $62 | Maintains | Outperform | Get Alert |
| 03/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.65 | 2561.99% | Jeff Jones32% | $43 → $44 | Maintains | Outperform | Get Alert |
| 03/07/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.24 | 3165.31% | Jeff Jones32% | $150 → $120 | Maintains | Outperform | Get Alert |
| 03/02/2023 | PMVP | Buy Now | PMV Pharma | $1.00 | 1400% | Jeff Jones32% | $28 → $15 | Maintains | Outperform | Get Alert |
| 03/01/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones32% | $125 → $150 | Maintains | Outperform | Get Alert |
| 01/27/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 4219.34% | Jeff Jones32% | $55 → $60 | Maintains | Outperform | Get Alert |
| 12/08/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones32% | $61 → $125 | Maintains | Outperform | Get Alert |
| 11/17/2022 | EVAX | Buy Now | Evaxion Biotech | $1.52 | 623.68% | Jeff Jones32% | $1600 → $1100 | Maintains | Outperform | Get Alert |
| 10/11/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | Jeff Jones32% | → $20 | Initiates | → Outperform | Get Alert |
| 10/04/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones32% | $50 → $65 | Maintains | Outperform | Get Alert |
| 09/12/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 4579.29% | Jeff Jones32% | $40 → $65 | Maintains | Outperform | Get Alert |
| 08/16/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 2779.56% | Jeff Jones32% | $30 → $40 | Maintains | Outperform | Get Alert |
| 07/19/2022 | NOVN | Buy Now | Novan | — | — | Jeff Jones32% | → $12 | Initiates | → Outperform | Get Alert |
| 07/18/2022 | CLRB | Buy Now | Cellectar Biosciences | $0.27 | 1956.07% | Jeff Jones32% | → $55 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.24 | 6838.78% | Jeff Jones32% | → $255 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | EVAX | Buy Now | Evaxion Biotech | $1.52 | 952.63% | Jeff Jones32% | → $1600 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | MBRX | Buy Now | Moleculin Biotech | $1.02 | 1270.94% | Jeff Jones32% | $30 → $210 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | VBLT | Buy Now | Vascular Biogenics | — | — | Jeff Jones32% | → $192.5 | Assumes | → Outperform | Get Alert |
| 06/09/2022 | PMVP | Buy Now | PMV Pharma | $1.00 | 3200% | Jeff Jones32% | $30 → $33 | Maintains | Outperform | Get Alert |
| 04/01/2022 | RAIN | Buy Now | Rain Oncology | $4.56 | 228.95% | Jeff Jones32% | → $15 | Initiates | → Outperform | Get Alert |
| 03/10/2022 | CMMB | Buy Now | Chemomab Therapeutics | $1.38 | 1349.7% | Jeff Jones32% | $30 → $20 | Maintains | Outperform | Get Alert |
| 03/02/2022 | PMVP | Buy Now | PMV Pharma | $1.00 | — | Jeff Jones32% | — | Upgrade | Perform → Outperform | Get Alert |
| 02/01/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.39 | 2059.67% | Jeff Jones32% | → $30 | Initiates | → Outperform | Get Alert |
| 12/10/2021 | PLRX | Buy Now | Pliant Therapeutics | $1.65 | 2319.99% | Jeff Jones32% | → $40 | Initiates | → Outperform | Get Alert |
| 12/08/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones32% | $35 → $50 | Upgrade | Perform → Outperform | Get Alert |
| 11/15/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones32% | — | Downgrade | Outperform → Perform | Get Alert |
| 10/05/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones32% | → $35 | Initiates | → Outperform | Get Alert |
| 08/19/2021 | PMVP | Buy Now | PMV Pharma | $1.00 | — | Jeff Jones32% | — | Initiates | → Perform | Get Alert |
| 05/07/2021 | CMMB | Buy Now | Chemomab Therapeutics | $1.38 | 2944.36% | Jeff Jones32% | → $42 | Initiates | → Outperform | Get Alert |
